M-PIMA
LIVE

Serial Number

79239079

Owner

ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY

Filing Date

Jun 14, 2018

Add to watchlist:

No watchlists yet
View on USPTO

M-PIMA Trademark

Serial Number: 79239079 • Registration: 6035854

M-PIMA is a trademark filed by ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY on June 14, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY (28 trademarks)

70 SIR JOHN ROGERSON'S QUAY
DUBLIN 2 , IE

Entity Type: 79

Abbott Rapid Diagnostics International Holdco Unlimited Company (2 trademarks)

70 Sir John Rogerson's Quay

Entity Type: 99

ALERE SWITZERLAND GMBH (76 trademarks)

BAHNHOFSTRASSE 28
ZUG CH-6300 , CH

Entity Type: 99

Trademark Details

Filing Date

June 14, 2018

Registration Date

April 21, 2020

Published for Opposition

February 4, 2020

Goods & Services

Computer hardware and software for use in medical testing and analysis of blood, bodily fluid and tissue; software for use in molecular diagnostic medical testing and analysis; software in the field of medical diagnostics for use in detecting and managing infectious diseases; computer operating software for laboratory instruments; computer software for diagnosing human diseases; laboratory instruments, namely, molecular diagnostic testing instruments that test for the presence of HIV and Filovirus, not for medical purposes; laboratory diagnostic analyzers for molecular diagnostic testing; laboratory molecular analyzers for use in molecular diagnostic medical testing and analysis

Medical diagnostic reagents; testing preparations for medical use, namely, cartridges pre-filled with dried formulated assay reagents, process controls, and buffers, for molecular diagnostic testing of bodily fluids and tissue for HIV diagnosis, HIV viral load, and Filovirus; molecular diagnostic tests for medical use for detecting and managing infectious diseases; diagnostic tests for medical use in the form of cartridges for measuring amounts of viruses; diagnostic tests for medical use in the form of cartridges for detecting infectious diseases; medical reagents contained in a cartridge for medical diagnostic use; in vitro diagnostic reagents contained in pre-filled cartridges for medical use; molecular diagnostic assays; medical diagnostic assays for testing of bodily fluids and tissue to detect and manage infectious diseases

Medical diagnostic instruments and parts therefore for molecular diagnostic analysis; medical diagnostic analyzers and parts therefore for detecting and managing infectious diseases; medical apparatus for determining and analyzing in vitro molecular interactions; medical apparatus for analyzing molecules, cells, tissues and organisms for detecting and managing infectious diseases; medical apparatus for analyzing nucleic acid and proteins for diagnosis and testing of infectious diseases; medical instruments used for blood, bodily fluid and tissue testing; nucleic acid medical testing instruments for diagnosis and management of infectious diseases; medical diagnostic instruments for detection of infectious diseases; pre-filled cartridges for detecting and managing infectious diseases

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 21, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Dec 20, 2024 NREP
CHANGE OF OWNER RECEIVED FROM IB
Mar 27, 2021 CHLD
CHANGE OF OWNER RECEIVED FROM IB
Mar 27, 2021 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 26, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 5, 2020 FICS
FINAL DISPOSITION PROCESSED
Aug 27, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 21, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2020 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 14, 2020 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 4, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 4, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jan 31, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 29, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 29, 2020 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 15, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 15, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 15, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 30, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 30, 2019 TEME
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 29, 2019 TCCA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 29, 2019 TROA
REFUSAL PROCESSED BY IB
Nov 17, 2018 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
Nov 15, 2018 NREP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 29, 2018 RFCS
REFUSAL PROCESSED BY MPU
Oct 29, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 16, 2018 RFCR
NON-FINAL ACTION WRITTEN
Oct 15, 2018 CNRT
ASSIGNED TO EXAMINER
Sep 30, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 28, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 23, 2018 REPR